Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapy

Published:2018-08-19 Issue:5 Volume:25 Page:1275-1281
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Beardslee Tyler¹,Draper Amber¹,Kudchadkar Ragini²³

Affiliation:

1. Department of Pharmacy, Winship Cancer Institute, Emory University, Druid Hills, USA

2. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Druid Hills, USA

3. Hematology and Medical Oncology Fellowship Program, Winship Cancer Institute, Emory University, Druid Hills, USA

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1078155218793709

Reference21 articles.

1. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

2. Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4)

3. Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents

4. Management of toxicities of immune checkpoint inhibitors

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity;Translational Oncology;2023-02

2. Cardiac Risk Factors for Immunotherapy;Current Clinical Pathology;2022

3. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis;Virchows Archiv;2021-08-02

4. Complications immunologiques sous inhibiteurs de « checkpoint » immunologique : spectre, physiopathologie et approche thérapeutique;La Revue de Médecine Interne;2021-06

5. Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report;Healthcare;2021-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3